Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 моноклональный антитело. Pidilizumab acts as a DLL1 антагонист. Pidilizumab has the potential for hematologic malignancies research.
Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.